Veuillez noter que la page demandée n’est pas disponible dans la langue par défaut sélectionnée. Vous utilisez notre plateforme dans une autre langue maintenant.
World's top 50 pharmaceutical and biotechnology companies based on R&D intensity in 2022
Loading statistic...
Basic Account
Get to know the platform
You only have access to basic statistics.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Small and medium-sized biotech companies
Biotech market
6
- Basic Statistic Percentage of global pharmaceutical sales by technology 2014-2028
- Premium Statistic Global biotech drug sales estimate 2012-2023
- Premium Statistic Projection of top 2024 pharma and biotech launches by revenue 2028
- Basic Statistic Enterprise value change in biopharma subsectors worldwide 2022-2023
- Basic Statistic Sales per employee of select U.S. biotech and drugs companies Q3 2023
- Premium Statistic Gross profit margin of select U.S. biotech and drugs companies Q3 2023
SME financing
6
- Basic Statistic Total raised capital in U.S. and Europe biotechnology industry 2015-2022
- Basic Statistic IPOs in U.S. and Europe biotechnology industry 2000-2022
- Basic Statistic Venture capital in U.S. and Europe biotechnology industry 2015-2022
- Basic Statistic United States biotech financing data 2015-2020
- Premium Statistic Value of top U.S. biotech IPOs 2022
- Basic Statistic U.S. investment for emerging therapeutic companies 2011-2022
Research & development
5
- Basic Statistic Top 50 global pharmaceutical and biotech companies by R&D intensity in 2022
- Basic Statistic Number of FDA approved NMEs, 2009-2018, by size of drug owner
- Basic Statistic Number of FDA approved NMEs, 2009-2018, by size of drug originator
- Basic Statistic Origin of new drugs licensed or acquired, 2014-2018, by company size
- Basic Statistic Alliances U.S. and Europe biotech companies by total potential value 2022
Growth
4
BioNTech vs. Moderna
8
- Basic Statistic Revenue of BioNTech 2017-2023
- Basic Statistic Moderna's revenue 2016-2023
- Basic Statistic Operating income of BioNTech 2017-2023
- Basic Statistic Moderna net income 2016-2023
- Basic Statistic Total assets of BioNTech 2017-2023
- Basic Statistic Moderna total assets 2016-2023
- Basic Statistic R&D expenses of BioNTech 2017-2023
- Basic Statistic R&D expenses of Moderna 2016-2023
Comparison of COVID-19 vaccines
5
- Basic Statistic Forecasted sales of select COVID-19 vaccines worldwide 2021-2022
- Basic Statistic COVID-19 vaccine comparison Biontech/Pfizer vs Moderna 2020
- Basic Statistic COVID-19 vaccine comparison adverse events Biontech vs Moderna 2020
- Premium Statistic BARDA funding for the development of COVID-19 vaccines in the U.S. 2021
- Basic Statistic Market reaction of COVID-19 vaccine makers to U.S. support of vaccine patents waiver
Further related statistics
19
- Top pharma and biotech companies by net sales growth in 2022
- Italy: number of statements about pharmaceuticals 2019, by brand
- Value of M&A transactions in biotechnology and pharmaceuticals sector 1985-2022
- Number of M&A transactions in biotechnology and pharmaceuticals sector 1985-2022
- Top 10 global pharmaceutical companies by revenue 2022
- Amount of top U.S. biotech venture financings 2022
- Enterprise value of top companies in non-oncology rare disease therapeutics 2017
- Top global generic pharmaceutical companies, by enterprise value 2016
- Enterprise value of generic pharmaceutical companies with a U.S. presence 2016
- U.S. generic pharmaceutical industry top acquisitions 2015
- Top global generic pharmaceutical companies 2015, by revenue
- Leading global pharmaceutical risers based on share price 2022
- Top pharmaceutical companies' SG&A to revenue rate 2022
- Leading global pharmaceutical risers based on market capitalization 2022
- U.S. venture investments in infectious disease companies 2006-2023
- Leading pharmaceuticals in online video ads in Poland 2016, by viewers and displays
- Spending on direct-to-consumer drug advertising in the U.S. 2016-2018, by media type
- Value of loans to drugs and pharmaceutical industry India 2020, by product type
- Market cap of select biopharma companies worldwide 2011 vs. 2020
Further Content: You might find this interesting as well
Statistics
- Top pharma and biotech companies by net sales growth in 2022
- Italy: number of statements about pharmaceuticals 2019, by brand
- Value of M&A transactions in biotechnology and pharmaceuticals sector 1985-2022
- Number of M&A transactions in biotechnology and pharmaceuticals sector 1985-2022
- Top 10 global pharmaceutical companies by revenue 2022
- Amount of top U.S. biotech venture financings 2022
- Enterprise value of top companies in non-oncology rare disease therapeutics 2017
- Top global generic pharmaceutical companies, by enterprise value 2016
- Enterprise value of generic pharmaceutical companies with a U.S. presence 2016
- U.S. generic pharmaceutical industry top acquisitions 2015
- Top global generic pharmaceutical companies 2015, by revenue
- Leading global pharmaceutical risers based on share price 2022
- Top pharmaceutical companies' SG&A to revenue rate 2022
- Leading global pharmaceutical risers based on market capitalization 2022
- U.S. venture investments in infectious disease companies 2006-2023
- Leading pharmaceuticals in online video ads in Poland 2016, by viewers and displays
- Spending on direct-to-consumer drug advertising in the U.S. 2016-2018, by media type
- Value of loans to drugs and pharmaceutical industry India 2020, by product type
- Market cap of select biopharma companies worldwide 2011 vs. 2020
European Commission, & Joint Research Centre. (December 14, 2023). World's top 50 pharmaceutical and biotechnology companies based on R&D intensity in 2022 [Graph]. In Statista. Retrieved April 29, 2024, from https://www.statista.com/statistics/524634/top-pharma-and-biotech-companies-by-randd-intensity-2014/
European Commission, und Joint Research Centre. "World's top 50 pharmaceutical and biotechnology companies based on R&D intensity in 2022." Chart. December 14, 2023. Statista. Accessed April 29, 2024. https://www.statista.com/statistics/524634/top-pharma-and-biotech-companies-by-randd-intensity-2014/
European Commission, Joint Research Centre. (2023). World's top 50 pharmaceutical and biotechnology companies based on R&D intensity in 2022. Statista. Statista Inc.. Accessed: April 29, 2024. https://www.statista.com/statistics/524634/top-pharma-and-biotech-companies-by-randd-intensity-2014/
European Commission, and Joint Research Centre. "World's Top 50 Pharmaceutical and Biotechnology Companies Based on R&d Intensity in 2022." Statista, Statista Inc., 14 Dec 2023, https://www.statista.com/statistics/524634/top-pharma-and-biotech-companies-by-randd-intensity-2014/
European Commission & Joint Research Centre, World's top 50 pharmaceutical and biotechnology companies based on R&D intensity in 2022 Statista, https://www.statista.com/statistics/524634/top-pharma-and-biotech-companies-by-randd-intensity-2014/ (last visited April 29, 2024)
World's top 50 pharmaceutical and biotechnology companies based on R&D intensity in 2022 [Graph], European Commission, & Joint Research Centre, December 14, 2023. [Online]. Available: https://www.statista.com/statistics/524634/top-pharma-and-biotech-companies-by-randd-intensity-2014/